Lana Medical Company (TADAWUL:9587)

Lana Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	84.09	48.63	40.8	31.97
Revenue Growth (YoY)	72.89%	19.20%	27.64%	-
Cost of Revenue	59.19	29.42	21.93	15.1
Gross Profit	24.9	19.21	18.87	16.87
Selling, General & Admin	15.3	11.61	9.04	8.47
Operating Expenses	16.42	19.58	12.35	9.55
Operating Income	8.48	-0.37	6.52	7.32
Interest Expense	-0.48	-0.34	-0.2	-0.08
Earnings From Equity Investments	5.37	-	-	-
Other Non Operating Income (Expenses)	0.25	0.18	0.29	0.54
EBT Excluding Unusual Items	13.62	-0.52	6.62	7.78
Gain (Loss) on Sale of Assets	-	-	-	0.01
Pretax Income	13.62	-0.52	6.62	7.79
Income Tax Expense	1.16	1.41	1.13	1.2
Net Income	12.46	-1.93	5.49	6.59
Net Income to Common	12.46	-1.93	5.49	6.59
Net Income Growth	-	-	-16.70%	-
Shares Outstanding (Basic)	5	5	5	3
Shares Outstanding (Diluted)	5	5	5	3
Shares Change (YoY)	18.38%	1.37%	37.11%	-
EPS (Basic)	2.31	-0.42	1.22	2.01
EPS (Diluted)	2.31	-0.42	1.22	2.01
EPS Growth	-	-	-39.25%	-
Free Cash Flow	-3.73	-2.43	0.5	-12.17
Free Cash Flow Per Share	-0.69	-0.53	0.11	-3.71
Gross Margin	29.61%	39.50%	46.25%	52.76%
Operating Margin	10.08%	-0.76%	15.99%	22.90%
Profit Margin	14.82%	-3.96%	13.46%	20.63%
Free Cash Flow Margin	-4.43%	-5.00%	1.22%	-38.06%
EBITDA	11.18	1.11	7.54	8.09
EBITDA Margin	13.29%	2.29%	18.47%	25.30%
D&A For EBITDA	2.7	1.48	1.01	0.77
EBIT	8.48	-0.37	6.52	7.32
EBIT Margin	10.08%	-0.76%	15.99%	22.90%
Effective Tax Rate	8.51%	-	17.03%	15.36%
Advertising Expenses	0.35	0.33	0.19	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.